Single-Dose Suprachoroidal AXT107 in Neovascular Age-Related Macular Degeneration: The Phase 1/2a DISCOVER Trial.

Pandey NB, Mirando AC, Robinson TJ, Almeida DRP, Dang S, Lally DR, Bridges WZ, Campochiaro PA, Popel AS, Green JJ

DOI: 10.64898/2026.09.19.26363031
Published: 2026 Oct 6
Container: medRxiv : the preprint server for health sciences
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.64898/2026.09.19.26363031,
  title = {Single-Dose Suprachoroidal AXT107 in Neovascular Age-Related Macular Degeneration: The Phase 1/2a DISCOVER Trial.},
  author = {Pandey NB and Mirando AC and Robinson TJ and Almeida DRP and Dang S and Lally DR and Bridges WZ and Campochiaro PA and Popel AS and Green JJ},
  year = {2026},
  journal = {medRxiv : the preprint server for health sciences},
  doi = {10.64898/2026.09.19.26363031},
  url = {https://doi.org/10.64898/2026.09.19.26363031}
}

RIS

TY  - JOUR
TI  - Single-Dose Suprachoroidal AXT107 in Neovascular Age-Related Macular Degeneration: The Phase 1/2a DISCOVER Trial.
AU  - Pandey NB
AU  - Mirando AC
AU  - Robinson TJ
AU  - Almeida DRP
AU  - Dang S
AU  - Lally DR
AU  - Bridges WZ
AU  - Campochiaro PA
AU  - Popel AS
AU  - Green JJ
PY  - 2026
JO  - medRxiv : the preprint server for health sciences
DO  - 10.64898/2026.09.19.26363031
UR  - https://doi.org/10.64898/2026.09.19.26363031
ER  -

APA

NB, P., AC, M., TJ, R., DRP, A., S, D., DR, L., WZ, B., PA, C., AS, P., & JJ, G. (2026). Single-Dose Suprachoroidal AXT107 in Neovascular Age-Related Macular Degeneration: The Phase 1/2a DISCOVER Trial.. medRxiv : the preprint server for health sciences. https://doi.org/10.64898/2026.09.19.26363031

Source records

pubmed · retrieved 2026-11-10T11:52:38.090Z